Assyro AI

Orange Book product · Generic (ANDA)

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Generic (ANDA)ANDA 202912DISCN LUPIN

At a glance

Dec 05, 2013

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 05, 2013

    12 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Strength

EQ 300MG BASE;150MG;300MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 202912

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.